Should a patient with primary intracerebral haemorrhage receive antiplatelet or anticoagulant therapy?

about

Antithrombotic medicines following intracerebral haemorrhage: where's the evidence?The risk of recurrent stroke after intracerebral haemorrhage.Long-term prognosis after intracerebral haemorrhage: systematic review and meta-analysis.

P2860

Q33949268-93B9E17A-131C-49DD-8991-2912266B7AED Q36227183-9DEF89F2-125E-4C27-9325-E9C473BA4611 Q38164972-DA150183-C87D-4BAF-A27B-BF1E9AE27D63

P2860

Should a patient with primary intracerebral haemorrhage receive antiplatelet or anticoagulant therapy?

Item

http://www.wikidata.org/entity/Q36234610

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Should a patient with primary ...... elet or anticoagulant therapy?

@ast

Should a patient with primary ...... elet or anticoagulant therapy?

@en

type

Item

label

Should a patient with primary ...... elet or anticoagulant therapy?

@ast

Should a patient with primary ...... elet or anticoagulant therapy?

@en

prefLabel

Should a patient with primary ...... elet or anticoagulant therapy?

@ast

Should a patient with primary ...... elet or anticoagulant therapy?

@en

P1476

Should a patient with primary ...... elet or anticoagulant therapy?

@en

P2093

Emma Nga

http://www.w3.org/2001/XMLSchema#string

Mushtaq Wani

http://www.w3.org/2001/XMLSchema#string

Ranjini Navaratnasingham

http://www.w3.org/2001/XMLSchema#string

P2860

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

Risk of early death and recurrent stroke and effect of heparin in 3169 patients with acute ischemic stroke and atrial fibrillation in the International Stroke Trial

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

Why do patients with atrial fibrillation not receive warfarin?

Apolipoprotein E genotype and cerebral amyloid angiopathy-related hemorrhage.

Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study.

Recurrent brain hemorrhage is more frequent than ischemic stroke after intracranial hemorrhage.

Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials.

P304

439-442

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BMJ.331.7514.439

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

7514

http://www.w3.org/2001/XMLSchema#string

P478

331

http://www.w3.org/2001/XMLSchema#string

P577

2005-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7650829

http://www.w3.org/2001/XMLSchema#string

P698

16110073

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation

P932

1188113

http://www.w3.org/2001/XMLSchema#string

Should a patient with primary intracerebral haemorrhage receive antiplatelet or anticoagulant therapy?

about

P2860

P2860

Should a patient with primary intracerebral haemorrhage receive antiplatelet or anticoagulant therapy?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932